Antiplatelet therapy to prevent coronary artery bypass graft occlusion.
Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Mass.
J E
JE
Buring
C H
CH
Hennekens
D001241:Aspirin / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D004176:Dipyridamole / Q000627:therapeutic use; D004338:Drug Combinations; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013442:Sulfinpyrazone / Q000627:therapeutic use
D004338:Drug Combinations; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone